Literature DB >> 2479429

Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions.

W Hinterberger1, G Adolf, P Bettelheim, K Geissler, C Huber, E Irschick, P Kalhs, U Köller, K Lechner, B Meister.   

Abstract

The production of interferons (IFNs), IFN-gamma, tumor necrosis factors (TNFs) and TNF-alpha (TNF-alpha) by peripheral blood mononuclear cells (PBMNCs) of untransfused and transfused, but otherwise untreated patients with severe aplastic anemia (SAA) was determined using bioassays and immunoassays. In untransfused and pretransfused SAA patients, spontaneous and lectin-induced production of these cytokines by PBMNCs was strongly enhanced. Cytokine production in untransfused SAA patients did not differ from that in pretransfused patients. Similar relative frequencies of activated (HLA-DR+) lymphocyte subpopulations present in the PBMNCs demonstrated cytokine overproduction per cells. Cytokine production was studied in three SAA patients before and after blood cell transfusions. Spontaneous and lectin-induced production of these cytokines was abnormally high and unaffected by blood transfusions. In another patient exhibiting abnormal cytokine production, the hematopoietic response to cyclosporin-A in vivo was accompanied by normalization of cytokine production in vitro. We conclude that overproduction of IFN-gamma and TNF-alpha by lectin-stimulated PBMNCs is an intrinsic abnormality of SAA unrelated to blood transfusions. Normalization of production of IFN-gamma and TNF-alpha accompanying a clinical response to cyclosporin-A may cautiously be taken as further evidence suggesting a pathogenetic role of cytokine overproduction in SAA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479429

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia.

Authors:  Carlo Dufour; Elisa Ferretti; Francesca Bagnasco; Oriana Burlando; Marina Lanciotti; Ugo Ramenghi; Paola Saracco; Maria Teresa Van Lint; Daniela Longoni; Giovanni Fernando Torelli; Marta Pillon; Anna Locasciulli; Aldo Misuraca; Milena La Spina; Andrea Bacigalupo; Vito Pistoia; Anna Corcione; Johanna Svahn
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

2.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 3.  Pathophysiology and treatment of aplastic anemia.

Authors:  Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

4.  Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia.

Authors:  D Nachbaur; A Gratwohl; M Herold; A Tichelli; M Slanicka; C Nissen; D Niederwieser; B Speck
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

5.  Overproduction of inhibitory hematopoietic cytokines by lipopolysaccharide-activated peripheral blood mononuclear cells in patients with aplastic anemia.

Authors:  H C Hsu; W H Tsai; L Y Chen; M L Hsu; C H Ho; C K Lin; S Y Wang
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

6.  Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation.

Authors:  D Bryder; V Ramsfjell; I Dybedal; K Theilgaard-Mönch; C M Högerkorp; J Adolfsson; O J Borge; S E Jacobsen
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.